#Peripheral Artery Disease Market Growth

[surbhijamdade]

Peripheral Artery Disease Market Report: Significant Growth Projected Through 2033

Peripheral Artery Disease Market Report: Significant Growth Projected Through 2033

Straits Research is pleased to announce the release of its comprehensive report on the global Peripheral Artery Disease (PAD) market. The peripheral artery disease market size was valued at USD 5.22 Billion in 2024. It is projected to reach from USD 5.66 Billion by 2025 to USD 10.75 Billion by 2033, growing at a CAGR of 8.35% during the forecast period (2025–2033).

Market Overview

Peripheral artery disease is characterized by the narrowing or blockage of arteries supplying blood to the limbs, primarily due to atherosclerosis. This condition affects over 200 million adults globally, highlighting an urgent need for effective treatment options and innovations in medical technology. The increasing prevalence of PAD, driven by an aging population and rising rates of chronic diseases such as diabetes and hypertension, is a key factor fueling market growth.

Request a Sample Report of Peripheral Artery Disease Market

Key Drivers of Market Growth

The growth of the PAD market is attributed to several factors:

Rising Prevalence of PAD: With an increasing number of individuals diagnosed with PAD, the demand for treatment options is surging.

Technological Advancements: Innovations in minimally invasive procedures and devices are enhancing treatment efficacy and patient outcomes.

Aging Population: The global demographic shift towards an older population is contributing to a higher incidence of PAD.

Improved Healthcare Infrastructure: Enhanced healthcare systems, particularly in developing regions, are facilitating better access to treatment.

Segmentation Analysis

The Peripheral Artery Disease market can be segmented based on type, treatment method, disease category, and end-user:

By Type:

Peripheral Angioplasty Balloons

Plaque Modification Devices

Peripheral Stents

Peripheral Catheters

Hemodynamic Flow Alteration Devices

Inferior Vena Cava (IVC) Filters

Peripheral Accessories

By Treatment:

Devices

Catheters

Plaque Modification Devices

Hemodynamic Flow Alteration Devices

Others

By Disease:

Lipid Lowering Drugs

Triple-H Therapy

Glucose Regulating Drugs

Blood Clot Preventing Drugs

Inotropes

Thrombolytic Agents

Anti-Inflammatory Agents

By End User:

Hospitals & Clinics

Ambulatory Surgical Clinics

Buy Peripheral Artery Disease Market Report here!

Key Developments in the Market

The report highlights several significant developments within the PAD market:

Major players are increasingly investing in research and development to innovate new treatments and devices.

Collaborations between healthcare providers and technology companies are leading to enhanced product offerings.

Regulatory approvals for advanced medical devices are expected to boost market growth.

Leading Players in the Peripheral Artery Disease Market

Straits Research identifies several top key players driving innovation and competition in the PAD market:

Abbott Laboratories

Cardinal Health, Inc.

Boston Scientific Corporation

Cook Medical

Becton Dickinson and Company

Terumo Corporation

Koninklijke Philips N.V.

AngioDynamics, Inc.

BIOTRONIK

B. Braun Melsungen AG

These companies are pivotal in shaping the future of PAD treatment through their commitment to quality and innovation.

Browse Full Report and TOC of Peripheral Artery Disease Market

Conclusion

The global Peripheral Artery Disease market is poised for substantial growth over the coming years. The combination of rising prevalence rates, technological advancements, and an aging population presents significant opportunities for stakeholders in this sector.For more detailed insights into the Peripheral Artery Disease market trends and forecasts, please refer to our full report or contact Straits Research directly.

About Straits Research

Straits Research is a leading provider of business intelligence, specializing in research, analytics, and advisory services aimed at delivering comprehensive insights through detailed reports. For further information or inquiries about this press release or our research services, please contact us at sales@straitsresearch.com or call +1 646 905 0080.

[waghaditi]

Angioplasty Balloons Market Growth Driven by Technological Advancements and Cardiovascular Diseases

The angioplasty balloons market has witnessed substantial growth in recent years due to various market drivers that are shaping its future. These drivers include an increase in cardiovascular diseases, advancements in medical technology, and an expanding global healthcare sector. This article explores the key market drivers that contribute to the expansion of the angioplasty balloons market and how they impact the industry.

Rising Incidence of Cardiovascular Diseases (CVDs) The growing prevalence of cardiovascular diseases, such as coronary artery disease (CAD) and peripheral artery disease (PAD), is one of the primary drivers of the angioplasty balloons market. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally. As the population ages and lifestyle-related factors like poor diet, smoking, and lack of physical activity increase, the incidence of CVDs continues to rise. This trend drives the demand for angioplasty procedures, which are essential for treating blockages in the arteries and restoring blood flow.

Technological Advancements in Medical Devices Technological innovation has significantly contributed to the angioplasty balloons market. Newer generations of angioplasty balloons, such as drug-eluting balloons (DEBs), cutting balloons, and bioresorbable balloons, are revolutionizing the treatment of vascular diseases. These advancements not only improve the efficiency of angioplasty procedures but also reduce the risk of restenosis (re-narrowing of arteries). DEBs, for example, are coated with drugs that help prevent the reoccurrence of blockages, leading to better long-term patient outcomes. Additionally, developments in balloon materials and designs make these devices more durable and easier to use.

Preference for Minimally Invasive Procedures There is a growing preference for minimally invasive medical procedures over traditional open surgeries. Patients and healthcare providers are opting for angioplasty, which is a minimally invasive procedure, due to its numerous benefits such as shorter recovery time, reduced complications, and lower risk of infection. The demand for angioplasty balloons is directly linked to this shift in preference. As more patients seek less invasive treatments for cardiovascular diseases, the angioplasty balloons market continues to grow, especially in developed regions where healthcare standards are high.

Increase in Healthcare Spending and Access to Advanced Healthcare As healthcare spending rises globally, particularly in emerging economies, the accessibility of advanced medical technologies, including angioplasty balloons, is improving. Many countries are investing in healthcare infrastructure, improving the availability of modern medical treatments. These developments have made angioplasty procedures more accessible to a larger portion of the population, driving the demand for angioplasty balloons. Additionally, as healthcare systems in developing countries become more sophisticated, the adoption of angioplasty balloons is expected to rise significantly.

Aging Population The aging global population is another key driver for the angioplasty balloons market. As people age, they become more susceptible to cardiovascular diseases. The elderly population is more likely to suffer from blocked arteries and other cardiovascular issues that require angioplasty. With a growing proportion of elderly individuals in developed countries and the aging population in emerging markets, the demand for treatments like angioplasty is increasing. Consequently, the need for angioplasty balloons is expected to rise significantly in the coming years.

Government Initiatives and Policies Government initiatives aimed at improving cardiovascular health are also driving the angioplasty balloons market. Many countries are investing in preventive healthcare measures, conducting awareness campaigns, and increasing funding for cardiovascular research. Furthermore, government policies that promote healthcare accessibility and insurance coverage for angioplasty procedures help increase the adoption of angioplasty balloons. These initiatives ensure that more people receive timely treatments, thus expanding the market for angioplasty balloons.

Growing Awareness of Cardiovascular Health There has been a significant increase in public awareness of cardiovascular health, particularly due to the efforts of health organizations, governments, and non-governmental organizations. As individuals become more aware of the risks associated with poor cardiovascular health, they are more likely to seek preventive treatments and diagnostic procedures. This growing awareness has led to earlier diagnosis and treatment of cardiovascular diseases, boosting the demand for angioplasty procedures and, by extension, angioplasty balloons.

Increased Investment in Medical Research Investments in cardiovascular research are driving innovation in the angioplasty balloons market. Ongoing research is focused on improving the performance of angioplasty balloons and developing new types of devices with enhanced features. For example, efforts are being made to create drug-eluting balloons that release medications more effectively, reduce the risk of restenosis, and provide longer-lasting results. As medical research continues to advance, the angioplasty balloons market will likely experience further growth, with new products emerging that meet the needs of both patients and healthcare providers.

Improved Reimbursement Policies In many countries, particularly in North America and Europe, improved reimbursement policies have made angioplasty procedures more affordable and accessible. The availability of insurance coverage for angioplasty balloons has led to a rise in their usage, especially among patients who might have otherwise opted for less expensive treatments. Reimbursement policies that cover innovative treatments such as drug-eluting balloons and cutting balloons further support market growth.

Emerging Market Potential The angioplasty balloons market is also expanding in emerging economies, where increasing healthcare investments and a rising middle class are creating opportunities for growth. As healthcare systems in countries like India, China, Brazil, and Russia improve, more people in these regions are gaining access to advanced cardiovascular treatments. The demand for angioplasty balloons is set to increase significantly as more patients seek effective solutions for cardiovascular diseases.

[globalinsightblog]

Atherectomy Devices Market: $1.3B in 2023 to $2.5B by 2033, 6.8% CAGR

Atherectomy Devices Market is a dynamic sector focused on developing and distributing medical devices designed to remove atherosclerotic plaque from blood vessels. These devices, including directional, rotational, orbital, and laser atherectomy systems, are pivotal in minimally invasive cardiovascular procedures, particularly for peripheral and coronary artery diseases. By enhancing patient outcomes and reducing the need for invasive surgeries, atherectomy devices have become essential tools in modern cardiovascular care.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS26127 &utm_source=SnehaPatil&utm_medium=Article

In 2023, the market recorded a robust volume of approximately 1.2 million units, with projections to increase to 1.8 million units by 2033. The directional atherectomy segment leads with a 45% market share, attributed to its efficiency in plaque removal and vessel wall preservation. Rotational atherectomy devices follow, holding a 30% share, favored for treating heavily calcified lesions. The hospital segment dominates the end-user landscape due to the increasing number of surgical procedures and advanced healthcare infrastructure, while ambulatory surgical centers reflect a shift towards cost-effective, outpatient treatments.

North America dominates the market, driven by a high prevalence of cardiovascular diseases and a well-established healthcare system. The United States leads with substantial investments in medical technology and a focus on minimally invasive procedures. Europe ranks second, with Germany and the UK contributing significantly due to rising healthcare expenditures and technological advancements. The Asia-Pacific region is anticipated to experience substantial growth, propelled by an aging population and increasing healthcare investments.

Market Segmentation

Type: Directional, Rotational, Orbital, Laser Atherectomy Devices

Product: Catheters, Guidewires, Sheaths, Balloon Angioplasty, Stents

Technology: Ultrasound, Optical Coherence Tomography, Near-Infrared Spectroscopy

Application: Coronary Artery Disease, Peripheral Artery Disease, Neurovascular Disease

End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Leading companies like Boston Scientific, Medtronic, and Cardiovascular Systems, Inc. play significant roles in shaping the market through innovation and expanded product portfolios. Competitive dynamics are heavily influenced by R&D investments and strategic alliances. Regulatory frameworks, especially in the U.S. and EU, are pivotal, affecting market access and compliance costs.

The market is projected to grow at a 10% annual rate, driven by technological advancements and the rising prevalence of cardiovascular diseases. Despite challenges like stringent regulatory requirements and high device costs, opportunities abound in emerging markets and AI integration in device functionality, promising enhanced procedural outcomes and market expansion.

#AtherectomyDevices #CardiovascularCare #MinimallyInvasive #PlaqueRemoval #PeripheralArteryDisease #CoronaryArteryDisease #DirectionalAtherectomy #RotationalAtherectomy #OrbitalAtherectomy #LaserAtherectomy #BostonScientific #Medtronic #CardiovascularInnovation #MedicalTechnology #HeartHealth

[kristinahertzz]

Medical Device Coating Market

Medical Device Coating Market Size, Share, Trends: Surmodics, Inc. Leads

Leveraging Advanced Coating Technologies to Enhance Medical Device Performance

Market Overview:

The global medical device coating market is estimated to increase at a 7.8% CAGR from 2024 to 2031. North America dominated the market in 2024, owing to its well-established healthcare industry, widespread acceptance of modern medical equipment, and rising prevalence of chronic diseases. Factors driving market expansion include the rising demand for minimally invasive surgical procedures, the increasing frequency of hospital-acquired infections (HAIs), technological advancements in medical device coatings, and a growing elderly population. These trends highlight the market's potential for innovation and growth as it continues to evolve to meet healthcare needs.

DOWNLOAD FREE SAMPLE

Market Trends:

Increasing demand for minimally invasive surgical procedures is a significant driver of the medical device coating industry. Minimally invasive operations provide various advantages over typical open surgeries, including less discomfort, quicker recovery, shorter hospital stays, and a lower chance of complications. Coated medical devices, such as cardiovascular stents, catheters, and guidewires, are essential in minimally invasive treatments because they improve device performance, biocompatibility, and patient safety. The expanding use of these procedures, combined with the increasing frequency of chronic diseases, is predicted to fuel demand for coated medical equipment.

Market Segmentation:

Antimicrobial coatings are likely to dominate the medical device coating market over the forecast period. These coatings protect medical devices from the adherence and growth of bacteria, fungi, and other microbes, lowering the risk of device-associated infections. Silver, copper, and zinc oxide are among the most often utilized antimicrobial compounds in medical device coatings due to their broad-spectrum action and long-term effectiveness. The rising prevalence of HAIs, combined with increased awareness of infection control and stringent regulations governing the use of medical equipment, is driving demand for antimicrobial coatings.

The cardiovascular devices section is predicted to have the fastest growth rate during the projection period. Cardiovascular devices such as stents, catheters, and heart valves are commonly used to treat a variety of cardiovascular ailments, including coronary artery disease, heart valve abnormalities, and peripheral arterial disease. Drug-eluting stents, which are coated with antiproliferative medicines to prevent restenosis, have transformed the treatment of coronary artery disease and are projected to fuel growth in the cardiovascular devices market.

Market Key Players:

The medical device coating industry is extremely competitive, with multiple global and regional participants. To strengthen their market position, key corporations invest in product innovation, technological advancements, and strategic collaborations. Major companies such as Surmodics, Inc., Hydromer, Inc., Specialty Coating Systems, Inc., Biocoat, Inc., DSM Biomedical, Inc., and Harland Medical Systems, Inc. are at the forefront, driving innovation and setting trends in the market.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[willyskristina]

U.S. Peripheral CTO Device Market

U.S. Peripheral CTO Device Market Size, Share, Trends: Boston Scientific Corporation Leads

Advanced imaging technologies enhance CTO device efficiency and procedural success rates

Market Overview: 

The U.S. peripheral CTO (chronic total occlusion) device market is expected to develop at a 7.2% CAGR from 2024 to 2031. The market value is predicted to rise from USD XX million in 2024 to USD YY million in 2031. The increased prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD) in the United States is the primary driver of this industry. Key factors include increased use of minimally invasive surgeries, technological developments in CTO devices, and a growing geriatric population. The industry is rising rapidly because of improved reimbursement rules for peripheral therapies and the increasing use of CTO devices in complex cardiovascular surgeries.

DOWNLOAD FREE SAMPLE

Market Trends: 

The U.S. peripheral CTO device market is seeing a substantial shift towards the integration of modern imaging technologies with CTO devices. This integration significantly improves the efficiency of CTO treatments while increasing success rates. Cutting-edge imaging techniques, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are increasingly being employed in tandem with CTO devices to give real-time, high-resolution visualization of occluded vessels. This trend allows interventionalists to more precisely negotiate difficult anatomies, lowering operation time and increasing patient outcomes.

Market Segmentation: 

Guidewires are the most popular device type in the U.S. peripheral CTO device market, accounting for over YY% of the market share. This supremacy is due to their vital role in traversing complicated occlusions, as well as their adaptability across diverse CTO methods. Guidewires are frequently the first devices utilised in CTO procedures, and they are critical in determining the procedure's effectiveness.

Continuous improvement in guidewire technology has been a fundamental driver of this segment's growth. Manufacturers are creating guidewires with better torque control, crossability, and visibility under fluoroscopy. A multi-centre study published in the Journal of Invasive Cardiology found that Boston Scientific's Fielder XT-R guidewire, built exclusively for CTO surgeries, had a 93% success rate in traversing difficult lesions.

Market Key Players:

Boston Scientific Corporation

Abbott Laboratories

Medtronic plc

Terumo Corporation

Becton, Dickinson, and Company (C.R. Bard)

Asahi Intecc Co., Ltd.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[stephengrand]

North America Balloon Catheters Market Size, Share, Trends, Growth, Analysis, Forecast | 2024-2032

The North America balloon catheters market is poised for significant growth in the coming years, with the market size valued at USD 1.3 billion in 2023. It is expected to expand at a robust compound annual growth rate (CAGR) of 10.59% during the forecast period of 2024-2032, reaching an estimated value of USD 3.3 billion by 2032. This growth is largely driven by the increasing prevalence of cardiovascular diseases, the adoption of minimally invasive surgical procedures, and technological advancements in balloon catheter design.

Balloon catheters are medical devices that play a vital role in treating a range of cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and other vascular disorders. The balloon catheter is inserted into a blood vessel, where it is inflated to widen narrowed or blocked arteries, thereby improving blood flow. This procedure, known as angioplasty, is commonly used to prevent heart attacks and strokes.

Get a Free Sample Report with Table of Contents : https://www.expertmarketresearch.com/reports/north-america-balloon-catheters-market/requestsample

This article delves into the key drivers, trends, challenges, market segmentation, and competitive landscape of the North American balloon catheters market. Additionally, it explores frequently asked questions (FAQs) about balloon catheters and highlights the key players shaping the market.

Market Drivers: Why Is the North America Balloon Catheters Market Expanding?

Several factors contribute to the expected growth of the balloon catheters market in North America:

1. Increasing Prevalence of Cardiovascular Diseases

The rise in cardiovascular diseases, including coronary artery disease, peripheral artery disease, and stroke, has been a major factor driving the demand for balloon catheter procedures. According to the American Heart Association, nearly 48% of the adult population in the U.S. has some form of cardiovascular disease. The growing number of patients requiring angioplasty or stenting has significantly boosted the adoption of balloon catheters.

2. Technological Advancements in Balloon Catheter Design

Innovation in balloon catheter design has improved their performance, safety, and ease of use, which has contributed to their increased adoption. Newer catheters are designed to have higher durability, smaller profiles, and better maneuverability, enabling surgeons to perform more complex procedures with greater precision. These advancements are expected to further fuel the growth of the market.

3. Shift Towards Minimally Invasive Procedures

Minimally invasive surgeries, including angioplasty, have become the preferred treatment option for many cardiovascular conditions due to their shorter recovery times, reduced risk of complications, and lower overall healthcare costs. Balloon catheter-based angioplasty procedures are less invasive than traditional surgery, which has increased their adoption across North America.

4. Aging Population

The ageing population in North America is another significant factor contributing to the growth of the balloon catheters market. As people age, the incidence of cardiovascular diseases increases, leading to a greater demand for interventional procedures like angioplasty, which often require balloon catheters.

5. Rising Healthcare Expenditure

Increased healthcare spending in North America, particularly in the U.S., has led to the adoption of advanced medical devices and treatments. The growing demand for high-quality healthcare services, along with the introduction of reimbursed medical procedures, is driving the use of balloon catheters for a range of cardiovascular treatments.

Market Challenges: Factors Limiting Growth

Despite the promising growth of the balloon catheters market, there are several challenges that could hinder its expansion:

1. High Cost of Balloon Catheters

One of the primary challenges facing the balloon catheter market is the high cost of advanced devices. While the technology behind balloon catheters continues to improve, the cost of these devices can be prohibitively high, especially for patients without insurance coverage or in regions with limited healthcare resources.

2. Risk of Complications During Procedure

While balloon catheter procedures are generally considered safe, there is still a risk of complications, such as arterial dissection, perforation, or restenosis (narrowing of the artery again after treatment). The occurrence of these complications can result in longer recovery times, additional treatments, or even the need for open surgery, which may deter some patients from opting for balloon angioplasty.

3. Regulatory Hurdles

The regulatory approval process for medical devices can be lengthy and costly. Manufacturers of balloon catheters must meet strict standards set by regulatory bodies, such as the U.S. Food and Drug Administration (FDA), which can delay the introduction of new products to the market.

Market Segmentation

The North American balloon catheters market can be segmented based on the following parameters:

1. Type of Balloon Catheters

Angioplasty Balloon Catheters: Used for coronary and peripheral artery procedures to widen narrowed or blocked arteries.

Cutting Balloon Catheters: These balloons have small blades that make incisions in the artery during inflation, enabling more effective dilation.

Scoring Balloon Catheters: These balloons have a scored surface that allows for better dilation of the arteries, particularly in cases of severe stenosis.

Drug-Eluting Balloon Catheters: These balloons are coated with drugs that help prevent restenosis after an angioplasty procedure.

2. Application Area

Coronary Artery Disease (CAD): Balloon catheters are extensively used in angioplasty for the treatment of CAD, one of the most common cardiovascular diseases in North America.

Peripheral Artery Disease (PAD): The growing incidence of PAD, particularly in older adults, has increased the demand for balloon catheters to treat narrowed arteries in the limbs.

3. End User

Hospitals: Hospitals are the primary end-users of balloon catheters, as they have the necessary infrastructure and skilled personnel to perform angioplasty procedures.

Cardiac Catheterization Laboratories (Cath Labs): Cath labs within hospitals are dedicated to performing procedures involving balloon catheters.

Ambulatory Surgical Centers (ASCs): These centers are seeing an increase in demand for minimally invasive procedures, including those involving balloon catheters.

Regional Analysis

North America holds the largest share of the balloon catheters market, with the U.S. leading the region in terms of market size and growth. The U.S. market is primarily driven by the high prevalence of cardiovascular diseases, the availability of advanced healthcare infrastructure, and the strong presence of leading balloon catheter manufacturers. Canada is also witnessing growth in the market, albeit at a slower pace due to its smaller population and healthcare system.

Competitive Landscape

The North America balloon catheters market is highly competitive, with several key players vying for market share. These companies are focusing on expanding their product portfolios, improving product quality, and entering into strategic partnerships to strengthen their market position. Some of the leading players in the market include:

1. Medtronic PLC

Medtronic is one of the dominant players in the balloon catheters market, with a wide range of angioplasty balloon catheters. The company has a strong presence in North America, with a broad distribution network and a well-established customer base.

2. Boston Scientific Corporation

Boston Scientific is another major player in the North American balloon catheter market. The company offers a wide range of balloon catheters for coronary and peripheral interventions, including drug-eluting balloon catheters.

3. Abbott Laboratories

Abbott is known for its innovative medical devices, including balloon catheters for cardiovascular interventions. The company has made significant strides in developing drug-eluting balloons for improved clinical outcomes.

4. Cook Medical

Cook Medical is a global leader in medical device innovation, providing a comprehensive range of balloon catheters for coronary and peripheral applications.

5. Terumo Corporation

Terumo is a Japanese medical device company with a strong presence in the North American balloon catheter market. The company’s offerings include cutting-edge balloon catheters for various vascular procedures.

6. Johnson & Johnson (Ethicon)

Ethicon, a subsidiary of Johnson & Johnson, is a leading player in the global balloon catheter market, providing high-quality devices for both coronary and peripheral artery procedures.

FAQs

1. What is a balloon catheter?

A balloon catheter is a medical device used in angioplasty procedures to widen narrowed or blocked arteries. It consists of a thin, flexible tube with a balloon at the tip that is inflated to compress plaque or blood clots in the arteries.

2. What are the types of balloon catheters?

The main types of balloon catheters are angioplasty balloon catheters, cutting balloon catheters, scoring balloon catheters, and drug-eluting balloon catheters.

3. What are the key applications of balloon catheters?

Balloon catheters are primarily used in the treatment of coronary artery disease (CAD) and peripheral artery disease (PAD), as well as for other vascular interventions.

4. What factors are driving the growth of the North America balloon catheters market?

The major drivers include the increasing prevalence of cardiovascular diseases, technological advancements in balloon catheter design, a shift towards minimally invasive surgeries, and an ageing population.

5. Who are the leading players in the North America balloon catheters market?

Key players include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Cook Medical, Terumo Corporation, and Johnson & Johnson (Ethicon).

[global-research-report]

Contrast Enhanced Ultrasound Market Players, Strategies And Outlook Status 2030

The global contrast enhanced ultrasound market is anticipated to reach USD 2.99 billion by 2030. It is projected to grow at a CAGR of 5.70% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic disorders such as cardiovascular ailments, cancer, and liver disease, growing geriatric population, and increasing technological advancements in the ultrasound imaging technology are the major factors anticipated to boost the contrast-enhanced ultrasound market growth over the forecast period. Growth in the market is further propelled using contrast-enhanced ultrasound over other imaging modalities like CT and MRI has become more popular due to its lower cost, portability, and lack of ionizing radiation.

The rising prevalence of cardiovascular diseases fueling the market growth. According to the World Health Organization (WHO), an estimated 17.9 million deaths occur each year due to cardiovascular diseases, making it the leading cause of death globally. In 2022, it is expected that there will be an increase in the number of people diagnosed with cardiovascular diseases. This is where contrast-enhanced ultrasound (CEUS) can play a crucial role in helping to detect and monitor these conditions. CEUS uses a contrast agent that enhances the ultrasound image, allowing for better visualization of the heart and blood vessels. It can be used to diagnose conditions such as heart valve disease, aortic aneurysm, and peripheral artery disease.

Furthermore, CEUS is a non-invasive and safe imaging modality that does not use ionizing radiation. This makes it a preferred option over other imaging modalities like CT and MRI, which use ionizing radiation. In 2021, a study published in the Journal of the American College of Cardiology showed that CEUS had high diagnostic accuracy in detecting coronary artery disease compared to other imaging modalities. With its many benefits, CEUS is becoming an increasingly important tool in diagnosing and managing cardiovascular diseases.

Contrast Enhanced Ultrasound Market Report Highlights

Based on product, the equipment segment held the largest revenue share in 2023. This can be attributed to the largest installed base of ultrasound imaging technology compatible with CEUS.

The contrast agents segment is expected to grow at the fastest CAGR of 6.32% during the forecast period owing to its approval of usage in the liver and pediatric imaging by the FDA.

Based on type, the non-targeted segment held the largest revenue share in 2023 as most of the commercially available contrast agents are non-targeted in nature.

The hospitals segment held the largest market share in 2023 owing to the increasing number of emergency visits with medical conditions such as abdominal pain, abdominal/thoracic trauma, and cardiac complications

The clinics segment is anticipated to witness lucrative CAGR over the forecast period owing to the realization of economic and patient care benefits with the adoption of sonography devices in practice among physicians at primary and secondary care

In Asia Pacific, the market is expected to grow at the fastest CAGR owing to the limited accessibility to advanced CT/MRI imaging modalities such as CT and MRI, and the growing burden of cardiovascular disorders in China and India.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global endoscopy visualization systems market size was valued at USD 25.1 billion in 2023 and is projected to grow at a CAGR of 6.8% from 2024 to 2030.

Asia Pacific bone grafts & substitutes market size was estimated at USD 662.4 million in 2024 and is projected to grow at a CAGR of 8.2% from 2025 to 2030.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels as well as provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global contrast enhanced ultrasound market report based on product, type, end-use, and region:

Contrast Enhanced Ultrasound Product Outlook (Revenue, USD Million, 2018 - 2030)

Equipment

Contrast Agents

Contrast Enhanced Ultrasound Type Outlook (Revenue, USD Million, 2018 - 2030)

Non-targeted

Targeted

Contrast Enhanced Ultrasound End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals

Clinics

Ambulatory Diagnostic Centers

Contrast Enhanced Ultrasound Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

South Korea

Thailand

Australia

Latin America

Brazil

Mexico

Argentina 

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Order a free sample PDF of the Contrast Enhanced Ultrasound Market Intelligence Study, published by Grand View Research.

[jameswilliam4u]

Global Vascular Stents Market Share, Trends & Forecast | 2024 - 2032

The global vascular stents market is a critical segment of the healthcare industry, especially within the realm of cardiovascular treatments. As of 2023, the market size reached a value of almost USD 10.57 billion and is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, reaching an estimated USD 17.10 billion by the end of the forecast period. This robust growth trajectory reflects the increasing demand for vascular stents, which are primarily used in the treatment of atherosclerosis, coronary artery disease, and peripheral artery disease (PAD).

[jayanthitbrc]

Global Stress Tests Equipment Market Analysis 2024: Size Forecast and Growth Prospects

The stress tests equipment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Stress Tests Equipment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The stress tests equipment market size has grown strongly in recent years. It will grow from $2.77 billion in 2023 to $2.99 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, aging population, healthcare infrastructure development, healthcare expenditure, awareness programs.

The stress tests equipment market size is expected to see strong growth in the next few years. It will grow to $3.87 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to remote monitoring solutions, personalized medicine, telemedicine expansion, data analytics and connectivity, emphasis on preventive healthcare. Major trends in the forecast period include integration of remote monitoring technologies, advancements in artificial intelligence and machine learning, rise of portable and wearable devices, emphasis on non-invasive testing methods, shift towards multimodal imaging solutions.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/stress-tests-equipment-global-market-report

Scope Of Stress Tests Equipment Market The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Stress Tests Equipment Market Overview

Market Drivers - The increasing prevalence of cardiovascular diseases is expected to propel the growth of the stress tests equipment market going forward. Cardiovascular disease (CVD) is a general term for conditions affecting the heart or blood vessels, including coronary heart disease, cerebrovascular disease, peripheral arterial disease, and rheumatic heart disease. Stroke is a type of cardiovascular disease that occurs when there is a loss of blood flow to part of the brain, causing lasting brain damage, long-term disability, or even death. Stress testing equipment plays a crucial role in diagnosing certain heart conditions, including coronary artery disease and angina, which can help in the early detection and prevention of cardiovascular diseases. For instance, in May 2023, according to a report published by the Centers for Disease Control and Prevention, a US-based national public health agency, stroke accounted for 1 in 6 deaths from cardiovascular disease in 2021 in the United States, occurring every 40 seconds, with associated costs reaching nearly $56.5 billion, while the death rate in 2021 increased to 41.1 per 100,000 from 38.8 per 100,000 in 2020. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the stress tests equipment market.

Market Trends - Major companies operating in the stress testing equipment market are increasing their focus on developing advanced solutions, such as smart cardiac stress testing systems, to gain a competitive edge in the market. A smart cardiac stress testing system is a type of cardiac stress test equipment that uses innovative technologies and smart design to solve common challenges associated with cardiac stress testing. For instance, in April 2021, Hill-Rom Holdings Inc., a US-based medical device company, launched the XScribe Cardiac Stress Testing System, a smart stress testing equipment to help solve common challenges associated with cardiac stress testing exams. The notable features include a 24-inch touchscreen interface with protocol-driven, pre-defined selections, 12-lead ECG interpretation for adults, adolescents, and children, bidirectional HL7 and DICOM connectivity based on standards, and the exclusive WAM Wireless Acquisition Module, which lessens barriers for clinical staff to navigate while enhancing patient comfort and safety in the stress lab. Additionally, VERITAS technology provides crucial information at every stage of the stress test with remarkable accuracy in real-time ST-segment monitoring, arrhythmia identification, and resting ECG interpretation.

The stress tests equipment market covered in this report is segmented –

1) By Product Type: Treadmill Stress Test Systems, Ergometry Equipment, Cardiopulmonary Exercise Testing (Cpet) Equipment, Exercise ECG Systems, Echocardiogram, Supplies And Accessories 2) By Technology: Wired, Wireless 3) By End-User: Hospitals, Diagnostic Centers, Ambulatory Care Centers, Research Institutes, Other End Users

Get an inside scoop of the stress tests equipment market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13938&type=smp

Regional Insights - North America was the largest region in the stress tests equipment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stress tests equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Cardinal Health Inc., Philips Healthcare (Koninklijke Philips N.V.), GE Healthcare, Schiller AG, Hill-Rom Holdings Inc., Nihon Kohden Corporation, Meditech Equipment, Contec Medical Systems, BPL Medical Technologies, Neurosoft SA, EB Neuro S.p.A., Progetti Medical, DRE Medical, Medisoft Group, Custo Med GmbH, Ganshorn Medizin Electronic, Nasiff Associates, Norav Medical, Clarity Medical Pvt Ltd, Innomed Medical Developing and Manufacturing, Cortex Biophysik GmbH, Trismed Co. Ltd., Medset Medizintechnik GmbH, Cardionics, MEC - Medical Electronic Construction, ANA-MED Co. Ltd., Nasan Medical Electronics Pvt., SEIVA s.r.o., Thor, MES, Piston Medical

Table of Contents 1. Executive Summary 2. Stress Tests Equipment Market Report Structure 3. Stress Tests Equipment Market Trends And Strategies 4. Stress Tests Equipment Market – Macro Economic Scenario 5. Stress Tests Equipment Market Size And Growth ….. 27. Stress Tests Equipment Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[stanleyhuds]

Vascular Grafts Market Size, Share, Demand, Growth, and Forecast 2025-2033

Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

The global vascular grafts market size reached USD 2.0 Billion in 2024.

The market is expected to reach 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.

North America leads the market, accounting for the largest vascular grafts market share.

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

The ongoing technological advancements in graft materials and design are supporting the market growth.

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

Prevalence of Cardiovascular Diseases:

The rising global cases of cardiovascular diseases (CVDs) are boosting market growth. These diseases often need surgery that uses vascular grafts.

Technological Advancements in Graft Materials and Design:

Technological progress in graft materials and designs is boosting the market. Today's vascular grafts are biocompatible, durable, and reduce complications like infections and rejection. Innovations such as drug-eluting and tissue-engineered grafts are also emerging. These grafts aim to better integrate with the body's tissues. Such advancements improve the safety and effectiveness of vascular surgeries, thus enhancing patient outcomes.

Preference for Minimally Invasive Surgeries (MIS):

Minimally invasive surgeries (MIS) are driving market growth. Procedures like endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) are less invasive than traditional surgeries. They also reduce hospital stays, lower infection risks, and speed up recovery. This boosts interest in specialized vascular grafts for these surgeries. Moreover, patients and doctors are leaning towards MIS for its benefits. This trend increases the demand for compatible vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

Endovascular Stent Grafts

Hemodialysis Access Grafts

Coronary Artery By-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

Polytetrafluoroethylene (PTFE)

Polyester

Polyurethane

Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

Cardiac Aneurysm

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

Abbott Laboratories

B. Braun SE (B. Braun Holding GmbH & Co. KG)

Becton, Dickinson & Company

Cook Group Incorporated

Cordis

CryoLife Inc.

Getinge AB

Heat Medical Europe BV

LeMaitre Vascular

Medtronic plc

Terumo Corporation

W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 

[globalinsightblog]

Drug Eluting Stent Market: $4.2B in 2023 to $8.5B by 2033, 7.0% CAGR

Drug Eluting Stent Market is at the forefront of cardiovascular treatment innovations, focusing on stents coated with medications to prevent artery blockage after surgery. These stents not only provide physical support to arteries but also deliver drugs to minimize restenosis, making them critical in modern cardiovascular treatments. The market’s growth is driven by advancements in stent technology, the rising prevalence of cardiovascular diseases, and a preference for minimally invasive procedures.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS26141 &utm_source=SnehaPatil&utm_medium=Article

In 2023, the market saw a robust volume of approximately 15 million units, with projections to reach 25 million units by 2033. Coronary stents lead the market, commanding a 65% share, primarily due to their efficacy in treating coronary artery diseases. Peripheral stents hold the remaining 35%, catering to peripheral artery conditions. The dominance of coronary stents is propelled by the increasing prevalence of cardiovascular diseases and technological advancements in stent design.

Polymer-based drug-eluting stents are prominent due to their superior drug delivery and biocompatibility. Bioabsorbable stents are also gaining traction, reflecting a shift towards more innovative and patient-friendly solutions. Among key players, Abbott Laboratories, Boston Scientific Corporation, and Medtronic hold significant market shares. Abbott Laboratories leads with continuous product innovation, while Boston Scientific focuses on expanding its global presence.

North America dominates the market, benefiting from advanced healthcare infrastructure and high adoption of innovative medical technologies. The United States leads within the region, driven by substantial investments in medical research and development. Europe follows closely, with Germany and the UK investing heavily in healthcare advancements and adopting cutting-edge medical devices. Asia-Pacific is emerging as a lucrative market, with China and India spearheading growth due to increasing healthcare expenditures and rising awareness of cardiovascular health.

Regulatory frameworks, such as the FDA’s stringent guidelines and the European CE marking requirements, play a crucial role in ensuring the safety and efficacy of drug-eluting stents. These regulations, while necessary, add compliance costs for manufacturers. Despite challenges like pricing pressures and the need for continuous R&D investments, the market is projected to grow at a 10% annual rate, spurred by technological innovations and increasing healthcare spending. The integration of AI in stent design and personalized medicine approaches are anticipated to open new growth avenues.

#DrugElutingStents #CardiovascularInnovation #StentTechnology #CoronaryStents #PeripheralStents #MinimallyInvasive #BioabsorbableStents #HeartHealth #MedicalAdvancements #AbbottLabs #BostonScientific #Medtronic #HealthcareInnovation #CardiacCare #FutureOfMedicine

[kristinahertzz]

Bare Metal Stents Market

Bare Metal Stents Market Size, Share, Trends: Medtronic plc Leads

Increasing Focus on Thin-Strut Bare Metal Stents Drives Market Forward

Market Overview: 

The Bare Metal Stents Market is projected to grow significantly from 2024 to 2031. North America currently dominates the market, accounting for the largest share of global revenue. Key metrics include the number of coronary and peripheral artery disease cases, stent implantation procedures, and regulatory approvals for new stent designs. The rising prevalence of cardiovascular diseases, technological advancements in stent design, and the cost-effectiveness of bare metal stents in certain patient groups are all contributing to the market's continued growth. However, the business is facing difficulties from the increasing use of drug-eluting stents and bioresorbable vascular scaffolds.

DOWNLOAD FREE SAMPLE

Market Trends: 

The development and use of thin-strut bare metal stents is a major market trend. These innovative designs are intended to reduce the risk of restenosis while enhancing overall patient outcomes. Thin-strut stents provide more flexibility, deliverability, and the potential for lower rates of in-stent restenosis than thicker stents. Recent study has shown that thin-strut bare metal stents can have similar safety and efficacy profiles to some first-generation drug-eluting stents, particularly in patients with a high risk of bleeding disorders.

Market Segmentation: 

The Coronary Artery Disease category presently commands the largest market share in the Bare Metal Stents business. This dominance stems primarily from the high global prevalence of coronary artery disease and the lengthy history of percutaneous coronary intervention (PCI) as a standard treatment option. While drug-eluting stents are the preferred option for many patients, bare metal stents nevertheless play an important role in several therapeutic situations. Recent advances in bare metal stent design, such as the development of cobalt-chromium alloys, have allowed for the production of thinner strut stents, potentially minimising the risk of restenosis while maintaining the mechanical strength required for vascular support.

Market Key Players: 

Prominent players in the Bare Metal Stents Market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG, Stentys SA, Hexacath, and MicroPort Scientific Corporation. These companies are at the forefront of the industry, continuously innovating and expanding their product portfolios to meet the evolving market demands. Their strategic initiatives and robust distribution networks have enabled them to maintain a strong market presence and drive growth.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[businessmarketreports]

An Overview of Canada Atherectomy Procedures Market: Trends and Insights

The Canadian atherectomy procedures market is experiencing steady growth, driven by increasing prevalence of peripheral artery disease (PAD), technological advancements in atherectomy devices, and a growing preference for minimally invasive treatments.

For more insights on the key segments of the Canada Atherectomy Procedures Market, download a free sample report

As an essential component of vascular interventions, atherectomy procedures are widely used to restore blood flow in patients with arterial blockages caused by plaque buildup.

Key Trends in the Canada Atherectomy Procedures Market

1. Rising Prevalence of PAD and Cardiovascular Diseases

PAD Incidence: An aging population and lifestyle-related risk factors, such as smoking, obesity, and diabetes, have contributed to the increasing prevalence of PAD in Canada.

Market Impact: This rise in PAD cases is driving demand for atherectomy procedures as an effective treatment option.

2. Shift Towards Minimally Invasive Procedures

Patient Preference: Minimally invasive techniques like atherectomy offer reduced recovery times, lower complication rates, and shorter hospital stays compared to traditional surgical interventions.

Market Driver: The shift toward minimally invasive vascular interventions is accelerating the adoption of atherectomy procedures.

3. Technological Advancements in Atherectomy Devices

Innovations: Modern atherectomy devices incorporate advanced features like laser technology, directional cutting, and rotational mechanisms, improving procedural outcomes and safety.

Market Impact: These advancements enhance the efficacy of atherectomy procedures, supporting their increased utilization.

4. Expanding Applications Beyond PAD

Broader Usage: Atherectomy procedures are being used in coronary and other vascular interventions beyond PAD, further driving market growth.

Clinical Trials: Ongoing studies evaluating the safety and effectiveness of atherectomy in various applications are contributing to its broader adoption.

5. Growing Awareness and Diagnosis Rates

Increased Diagnosis: Efforts to improve awareness of PAD among patients and healthcare professionals are leading to earlier diagnosis and treatment, boosting procedure volumes.

Healthcare Policies: Government initiatives and campaigns promoting vascular health also play a crucial role in market expansion.

Market Insights: Drivers and Challenges

Key Drivers

Aging Population: The increasing number of elderly individuals in Canada, who are more prone to PAD and other vascular conditions, drives demand for atherectomy procedures.

Favorable Reimbursement Policies: Coverage for atherectomy procedures under Canada's healthcare system makes them more accessible.

Specialist Training: Enhanced training programs for interventional radiologists and vascular surgeons improve procedural success rates and adoption.

Key Challenges

Cost Constraints: The high cost of advanced atherectomy devices and procedures can limit adoption, particularly in smaller healthcare facilities.

Competition from Alternative Treatments: Procedures such as angioplasty and stenting remain popular alternatives, posing competition to atherectomy.

Regulatory Approvals: Strict regulatory processes for new atherectomy devices may delay market entry and limit availability.

Procedure Types

1. Directional Atherectomy

Mechanism: Removes plaque by cutting it away with a specialized catheter.

Applications: Commonly used for large, calcified plaques in peripheral arteries.

Advantages: Provides precise plaque removal with minimal vessel trauma.

2. Rotational Atherectomy

Mechanism: Utilizes a high-speed rotating burr to grind hard, calcified plaques into fine particles.

Applications: Frequently employed in coronary artery disease cases.

Advantages: Effective for treating heavily calcified lesions.

3. Laser Atherectomy

Mechanism: Uses laser energy to vaporize plaque into tiny particles.

Applications: Suitable for soft plaques and in-stent restenosis.

Advantages: Reduces the risk of vessel damage and embolization.

4. Orbital Atherectomy

Mechanism: A rotating, eccentrically shaped sanding device removes plaque while preserving healthy tissue.

Applications: Effective for eccentric and calcified lesions.

Advantages: Provides uniform plaque modification with low complication rates.

Key Market Players

The Canadian atherectomy procedures market includes a mix of global and regional device manufacturers offering a wide range of solutions:

Medtronic

Devices: HawkOne™ and TurboHawk™ directional atherectomy systems.

Strengths: Comprehensive product portfolio and strong presence in the vascular devices market.

Boston Scientific

Devices: Rotablator™ rotational atherectomy system.

Strengths: Innovation in coronary and peripheral vascular devices.

Cardiovascular Systems, Inc. (CSI)

Devices: Diamondback 360® orbital atherectomy system.

Strengths: Focus on novel technologies for treating calcified lesions.

Philips (Spectranetics)

Devices: Turbo-Elite™ laser atherectomy catheter.

Strengths: Expertise in laser technology for vascular interventions.

Future Outlook

The Canadian atherectomy procedures market is poised for growth in the coming years, supported by:

Advancements in Imaging: Integration of advanced imaging modalities, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), for precise plaque characterization.

Improved Patient Outcomes: Continued innovation in device design to reduce complications and improve efficacy.

Emerging Technologies: Adoption of robotic-assisted atherectomy systems for enhanced procedural precision.

Collaborations: Increased partnerships between device manufacturers and healthcare providers to improve access and affordability.

Conclusion

The atherectomy procedures market in Canada is undergoing significant advancements, fueled by growing demand for minimally invasive vascular treatments and technological innovations. With an aging population, increasing PAD prevalence, and strong healthcare infrastructure, the market offers substantial growth opportunities. By addressing cost barriers and expanding the scope of applications, stakeholders can capitalize on this evolving segment.

[mukeshdalgavev123]

LDL Test Market Trends, Growth, and Opportunities 2024

Industrial Snapshot of LDL Test Market

The LDL Test Market Report is a treasured source of insightful data for business strategists. It provides an in-depth assessment of numerous features of industries like market overview, present progress valuations, historical and future Studies, current trends, SWOT valuations, and clients operating in several regions. The study provides valuable information to magnify the understanding, scope, and segments of this report. The report covers a comprehensive analysis of LDL Test Market segmentation, regional and country breakdowns. This research will offer a clear and exact idea about the whole industry to the readers to make beneficial decisions.

According to Straits Research, the global LDL Test market size was valued at USD 8.45 billion in 2023. It is projected to reach from USD 8.96 billion in 2024 to USD 14.45 billion by 2032, growing at a CAGR of 6.15% during the forecast period (2024–2032).

This study pinpoints noteworthy trends influencing the trajectory of the Gesture Recognition market's expansion. Within this recently issued report, crucial dynamics encompassing drivers, limitations, and prospects are underscored. These aspects hold relevance for well-established market entities as well as emerging stakeholders engaged in the realms of production and supply.

Request a Sample Report @ https://straitsresearch.com/report/ldl-test-market/request-sample

Competitive Analysis

The report contains an in-depth analysis of the vendor’s profile, including financial health, business units, key business priorities, SWOT, strategies, and views.

Hoffmann-La Roche Ltd.

Sekisui Diagnostics

Express Biotech International

Sigma-Aldrich Co. LLC

Randox Laboratories Ltd.

Reckon Diagnostics

Quest Diagnostics Incorporated

DiaSys Diagnostics India Private Limited

Eurofins Scientific

Kopibeskyttet Unilabs Labhåndbok

Atlas Medical

Eurolyser Diagnostics GmbH

Laboratory Corporation of America

Diazyme Laboratories Inc.

Thermo Fisher Scientific Inc.

The vendors have been identified based on the portfolio, geographical presence, marketing & distribution channels, revenue generation, and significant R&D investments.

Request Sample Report of Global LDL Test Market @ https://straitsresearch.com/report/ldl-test-market/request-sample

Vendors across different verticals are planning for high investments in this market, and as a result, the market is expected to grow at an impressive rate in the upcoming years. The key players are adopting various organic and inorganic growth strategies such as mergers & acquisitions, collaboration & partnerships, joint ventures, and a few other strategies to be in a strong position in the global market.

Market Segmentation Analysis

The report provides a wide-ranging evaluation of the market, providing in-depth qualitative insights, historical data, and supportable projections along with the assumptions about the LDL Test Market size. The projections featured in the report have been derived using proven research methodologies and assumptions based on the vendor’s portfolio, blogs, white papers, and vendor presentations. Thus, the research report represents every side of the LDL Test Market and is segmented on the basis of regional markets, offerings, applications, and end-users.

By Type

LDL-C

LDL-P

LDL-B

Others

By Component

Devices

Syringes and Needles

Spectrophotometers

Kits and Reagents

Toxicity Assays Kit

Blood Chemistry Assays Kit 

Cytotoxicity Assays Kit

Others

By Applications

Atherosclerosis

Obesity

Dyslipidemia

Diabetes

Angina

Stroke Carotid Artery Disease

Peripheral Arterial Disease

Others

By End-User

Hospitals

Clinics

Pharmaceutical and Biotechnological Companies

Diagnostic Centers

Others

Access Detailed Segmentation @ https://straitsresearch.com/report/ldl-test-market/segmentation

Regional Analysis for LDL Test Market

The regional analysis offers a comprehensive view of the LDL Test Market sales and growth across global and country-level markets. It provides volume and market size data by region, with insights into growth trends in countries like the United States, Canada, Germany, France, China, Japan, and more. The analysis also covers major regions such as North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Benefits

LDL Test Market Industry companies to ensure business continuity with powerful protection by constantly checking the report and representing attractive growth opportunities for the companies. LDL Test Market handles all the needs of the operators by allowing them to improve their services and concentrate on their core business. LDL Test Market Research aims to increase business agility and reduce operational and capital expenditure with improved technology rollouts and capacity planning. The report discusses service types and regions related to this LDL Test Market. Further, the report provides details about the major challenges affecting the market growth.

Buy Now: https://straitsresearch.com/buy-now/ldl-test-market

Other Features of the Report:

Provides a thorough analysis of the key strategies with a focus on the corporate structure, R&D methods, localization strategies, production capabilities, sales, and performance in various companies.

Provides valuable insights into the product portfolio, including product planning, development, and positioning.

Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, Europe, or Asia.

About Us:

StraitsResearch.com is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.

Contact Us: Email: sales@straitsresearch.com Website: https://straitsresearch.com/